Back to collectionInstitutional Tokenization Adds Issuers, Pilots and Distribution
Injective, Anchorpoint and Stellar illustrate different stages between representation and usable settlement.
Injective said its institutional services arm obtained US transfer-agent registration. Its wider work included Injective Mint, a MiCA white paper and tokenization trials with POSCO and LG CNS. The registration concerns the entity's transfer-agent role, while the trials concern how specific assets are represented and handled.
Standard Chartered-backed Anchorpoint's HKDAP entered a restricted beta phase. Its August 12 white paper dates Beta Access to that day and specifies a wholesale model through authorized distributors; its FAQ limits beta access to corporates and professional investors. This is narrower than unrestricted retail availability.
Stellar reported about $490 million in tokenized non-US government debt, a category lead since February and a broader RWA total approaching $4 billion. A ten-team accelerator with CV Labs focused on payments, remittances and emerging-market financial infrastructure; Chainlink's support for Wyoming's FRNT added another government-linked payment example. Asset stock, development cohorts, registration and payment access measure different things. Transfer and redemption rights determine what those represented assets can actually do.